Medicine and Dentistry
Tumor Xenograft
100%
Triple Negative Breast Cancer
100%
Programmed Death 1 Receptor
100%
Immunotherapy
50%
Neoplasm
33%
Tumor Progression
33%
Xenograft
33%
Breast Cancer
16%
Cytokine
16%
Tumor Model
16%
Diabetes Mellitus
16%
Immunity
16%
Hematopoietic Cell
16%
Melanoma Cell
16%
Chlordane
16%
Lung Metastasis
16%
Clinical Observation
16%
Intravenous Drug Administration
16%
CD20
16%
Engraftment
16%
CD3 Antigen
16%
CD8 Antigen
16%
Antibody Therapy
16%
CTLA-4
16%
Melanoma Cell Line
16%
Human Leukocyte Antigen
16%
Severe Combined Immunodeficiency
16%
Immunology and Microbiology
Mouse Model
100%
Xenograft
100%
Programmed Death 1 Receptor
100%
Humanized Mouse
100%
Immunotherapy
60%
Cytokine
20%
Hematopoietic Cell
20%
CD8
20%
Immunity
20%
CD3 Antigen
20%
Preclinical Study
20%
CD20
20%
Human Leukocyte Antigen
20%
Engraftment
20%
CD34
20%
Severe Combined Immunodeficiency
20%
CTLA-4
20%
CD68
20%
Melanoma Cell
20%
Melanoma Cell Line
20%
CD33
20%
Biochemistry, Genetics and Molecular Biology
Synapsin I
100%
Mouse Model
100%
Cell Death
100%
Tumor Progression
40%
Cytokine
20%
Hematopoietic Cell
20%
Immunity
20%
CD8
20%
Animal Model
20%
CD34
20%
Human Leukocyte Antigen
20%
Preclinical Study
20%
CD68
20%
CD20
20%
CTLA-4
20%
CD33
20%
Keyphrases
Anti-programmed Cell Death Protein 1
100%